Issued 2026-09-16 at $46.76 · now $46.76 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, VRNS has typically landed between $37.17 and $55.91 — a range of −20.5% to +19.6% from the issuance price $46.76.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
3,135 overlapping 1 month windows · 2014-02-28 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($46.76) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where VRNS has typically landed a month from the 2026-09-16 close of $46.76 — the range is history, not a prediction.
- now $46.76 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $47.07 (+0.7%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $43.27–$50.86
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $37.17–$55.91
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2025-10-23 | −49.7% | −49.7% | +1.1% |
| 2025-10-24 | −49.5% | −49.7% | +1.1% |
| 2025-10-22 | −48.7% | −48.7% | +2.9% |
| 3 best | |||
| 2014-12-10 | +50.2% | +0.0% | +50.2% |
| 2014-12-08 | +49.3% | +0.0% | +49.3% |
| 2014-12-11 | +49.2% | +0.0% | +50.2% |
3,135 overlapping windows · 2014-02-28 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-09 | Faitelson Yakov | director | Purchase | 26,725 @ $22.41 | $599K | +1.2% of holding | −3.4% | +52.8% | 2,185,387 | Form 4 · filed 1 day after the trade |
| 2026-02-09 | Bass David | officer | Purchase | 2,980 @ $23.47 | $70K | +0.3% of holding | −3.4% | +52.8% | 1,042,924 | Form 4 · filed 1 day after the trade |
| 2026-02-06 | Kess Avrohom J. | director | Purchase | 17,800 @ $22.29 | $397K | +56.3% of holding | +7.7% | +74.8% | 49,403 | Form 4 · filed 4 days after the trade |
| 2026-02-06 | GAVIN JOHN J JR | director | Purchase | 5,000 @ $22.54 | $113K | +1.9% of holding | +7.7% | +74.8% | 273,666 | Form 4 · filed 4 days after the trade |
| 2025-08-29 | Melamed Guy | officer | Sale | 1,500 @ $59.59 | $89K | −0.4% of holding | −6.2% | −66.2% | 412,105 | Form 4 · filed 4 days after the trade |
| 2025-08-28 | Melamed Guy | officer | Sale | 3,892 @ $59.52 | $232K | −0.9% of holding | −2.3% | −67.4% | 413,605 | Form 4 · filed 5 days after the trade |
| 2025-08-22 | Melamed Guy | officer | Sale | 10,400 @ $59.53 | $619K | −2.4% of holding | −4.4% | −70.4% | 417,497 | Form 4 · filed 4 days after the trade |
| 2025-08-13 | Melamed Guy | officer | Sale | 42,705 @ $57.72 | $2.5M | −9.1% of holding | −5.2% | −63.0% | 427,897 | Form 4 · filed 2 days after the trade |
| 2025-08-01 | Melamed Guy | officer | Sale | 51,889 @ $55.10 | $2.9M | −9.9% of holding | +0.9% | −59.1% | 470,602 | Form 4 · filed same day |
| 2025-08-01 | VAN DEN BOSCH FRED | director | Sale | 3,000 @ $55.08 | $165K | −2.3% of holding | +0.9% | −59.1% | 128,666 | Form 4 · filed same day |
| 2025-06-04 | VAN DEN BOSCH FRED | director | Sale | 6,000 @ $50.00 | $300K | −4.4% of holding | −2.2% | −52.3% | 131,666 | Form 4 · filed same day |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
55 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-05-31 | Gottlieb Dov | officer | Withheld for tax | 9,264 | 265,774 | Form 4 |
| 2026-05-22 | Melamed Guy | officer | Withheld for tax | 104,440 | 504,662 | Form 4 |
| 2026-04-30 | COMOLLI KEVIN E | director | Award / grant | 7,224 | 46,228 | Form 4 |
| 2026-04-30 | Segev Ofer | director | Award / grant | 7,224 | 91,247 | Form 4 |
| 2026-04-30 | Aued Carlos | director | Award / grant | 7,224 | 30,247 | Form 4 |
| 2026-04-30 | VAN DEN BOSCH FRED | director | Award / grant | 7,224 | 135,890 | Form 4 |
| 2026-04-30 | MENDOZA THOMAS F | director | Award / grant | 7,224 | 72,425 | Form 4 |
| 2026-04-30 | Korkus Ohad | director | Award / grant | 7,224 | 122,984 | Form 4 |
| 2026-04-30 | Kess Avrohom J. | director | Award / grant | 7,224 | 56,627 | Form 4 |
| 2026-04-30 | GAVIN JOHN J JR | director | Award / grant | 7,224 | 280,890 | Form 4 |
| 2026-04-30 | Iohan Gili | director | Award / grant | 7,224 | 34,828 | Form 4 |
| 2026-04-30 | Prishkolnik Rachel | director | Award / grant | 7,224 | 32,938 | Form 4 |
| 2026-02-27 | Faitelson Yakov | director | Withheld for tax | 369,576 | 1,509,180 | Form 4 |
| 2026-02-27 | Pomeroy Greg | officer | Withheld for tax | 32,581 | 281,313 | Form 4 |
| 2026-02-27 | Gottlieb Dov | officer | Withheld for tax | 20,206 | 275,038 | Form 4 |
| 2026-02-09 | Faitelson Yakov | director | Gift | 47,000 | 83,869 | Form 4 |
| 2026-02-09 | Faitelson Yakov | director | Gift | 87,000 | 2,098,387 | Form 4 |
| 2026-02-09 | Faitelson Yakov | director | Gift | 31,928 | 285,312 | Form 4 |
| 2026-02-09 | Faitelson Yakov | director | Gift | 31,928 | 285,312 | Form 4 |
| 2026-02-06 | Bass David | officer | Award / grant | 169,095 | 1,039,944 | Form 4 |
| 2026-02-06 | Gottlieb Dov | officer | Award / grant | 66,226 | 294,862 | Form 4 |
| 2026-02-06 | Faitelson Yakov | director | Award / grant | 315,674 | 2,158,662 | Form 4 |
| 2026-02-06 | Melamed Guy | officer | Award / grant | 125,359 | 608,662 | Form 4 |
| 2026-02-06 | Pomeroy Greg | officer | Award / grant | 75,056 | 313,449 | Form 4 |
| 2026-02-02 | Bass David | officer | Award / grant | 63,735 | 870,849 | Form 4 |
| 2026-02-02 | Gottlieb Dov | officer | Award / grant | 12,497 | 228,636 | Form 4 |
| 2026-02-02 | Melamed Guy | officer | Award / grant | 70,967 | 483,303 | Form 4 |
| 2026-02-02 | Pomeroy Greg | officer | Award / grant | 23,011 | 238,393 | Form 4 |
| 2026-02-02 | Faitelson Yakov | director | Award / grant | 162,460 | 1,842,988 | Form 4 |
| 2025-09-11 | Faitelson Yakov | director | Gift | 54,735 | 1,680,528 | Form 4 |
| 2025-09-11 | Faitelson Yakov | director | Gift | 31,928 | 36,869 | Form 4 |
| 2025-06-02 | Gottlieb Dov | officer | Withheld for tax | 18,333 | 215,935 | Form 4 |
| 2025-05-08 | Iohan Gili | director | Award / grant | 4,178 | 27,604 | Form 4 |
| 2025-05-08 | Prishkolnik Rachel | director | Award / grant | 4,178 | 25,714 | Form 4 |
| 2025-05-08 | Kess Avrohom J. | director | Award / grant | 4,178 | 31,603 | Form 4 |
| 2025-05-08 | Korkus Ohad | director | Award / grant | 4,178 | 115,760 | Form 4 |
| 2025-05-08 | COMOLLI KEVIN E | director | Award / grant | 4,178 | 39,004 | Form 4 |
| 2025-05-08 | Aued Carlos | director | Award / grant | 4,178 | 23,023 | Form 4 |
| 2025-05-08 | Segev Ofer | director | Award / grant | 4,178 | 84,023 | Form 4 |
| 2025-05-08 | VAN DEN BOSCH FRED | director | Award / grant | 4,178 | 137,666 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.